5TOL | pdb_00005tol

CRYSTAL STRUCTURE OF BETA-SITE APP-CLEAVING ENZYME 1 COMPLEXED WITH N-(3-((4AS,7AS)-2-AMINO-4,4A,5,6-TETRAHYDRO-7AH-FURO[2,3-D][1,3]THIAZIN-7A-YL)-4-FLUOROPHENYL)-5-BROMO-2-PYRIDINECARBOXAMIDE


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.51 Å
  • R-Value Free: 
    0.257 (Depositor), 0.249 (DCC) 
  • R-Value Work: 
    0.201 (Depositor), 0.199 (DCC) 
  • R-Value Observed: 
    0.204 (Depositor) 

wwPDB Validation 3D Report Full Report

Validation slider image for 5TOL

Ligand Structure Quality Assessment 


This is version 1.2 of the entry. See complete history

Literature

Discovery of furo[2,3-d][1,3]thiazinamines as beta amyloid cleaving enzyme-1 (BACE1) inhibitors.

Wu, Y.J.Guernon, J.Rajamani, R.Toyn, J.H.Ahlijanian, M.K.Albright, C.F.Muckelbauer, J.Chang, C.Camac, D.Macor, J.E.Thompson, L.A.

(2016) Bioorg Med Chem Lett 26: 5729-5731

  • DOI: https://doi.org/10.1016/j.bmcl.2016.10.055
  • Primary Citation Related Structures: 
    5TOL

  • PubMed Abstract: 

    This Letter describes the synthesis and structure-activity relationships of a series of furo[2,3-d][1,3]thiazinamine BACE1 inhibitors. The co-crystal structure of a representative thiazinamine 2e bound with the BACE1 active site displayed a binding mode driven by interactions with the catalytic aspartate dyad and engagement of the biaryl amide toward the S1 and S3 pockets. This work indicates that furo[2,3-d]thiazine can serve as a viable bioisostere of the known furo[3,4-d]thiazine.


  • Organizational Affiliation
    • Research and Development, Bristol-Myers Squibb, 5 Research Parkway, Wallingford, CT 06492, USA. Electronic address: Yong-Jin.Wu@bms.com.

Macromolecule Content 

  • Total Structure Weight: 46.37 kDa 
  • Atom Count: 2,997 
  • Modeled Residue Count: 374 
  • Deposited Residue Count: 412 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Beta-secretase 1412Homo sapiensMutation(s): 2 
Gene Names: BACE1BACEKIAA1149
EC: 3.4.23.46
UniProt & NIH Common Fund Data Resources
Find proteins for P56817 (Homo sapiens)
Explore P56817 
Go to UniProtKB:  P56817
PHAROS:  P56817
GTEx:  ENSG00000186318 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP56817
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
7H3

Query on 7H3



Download:Ideal Coordinates CCD File
B [auth A]N-{3-[(4aR,7aR)-2-amino-4,4a,5,6-tetrahydro-7aH-furo[2,3-d][1,3]thiazin-7a-yl]-4-fluorophenyl}-5-bromopyridine-2-carboxamide
C18 H16 Br F N4 O2 S
DACRJCISVSMZQT-XTZNXHDOSA-N
Binding Affinity Annotations 
IDSourceBinding Affinity
7H3 BindingDB:  5TOL IC50: 33 (nM) from 1 assay(s)

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.51 Å
  • R-Value Free:  0.257 (Depositor), 0.249 (DCC) 
  • R-Value Work:  0.201 (Depositor), 0.199 (DCC) 
  • R-Value Observed: 0.204 (Depositor) 
Space Group: P 61 2 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 101.49α = 90
b = 101.49β = 90
c = 171.237γ = 120
Software Package:
Software NamePurpose
REFMACrefinement
PDB_EXTRACTdata extraction
XDSdata reduction
SCALAdata scaling

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2016-11-23
    Type: Initial release
  • Version 1.1: 2016-12-07
    Changes: Database references
  • Version 1.2: 2024-11-06
    Changes: Data collection, Database references, Structure summary